Cetera Advisor Networks’s Amneal Pharmaceuticals AMRX Stock Holding History

Cetera Advisor Networks’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,055	Closed	-$84K	–	2069
2022 Q1	$84K	Sell	20,055 -58,000	-74%	-$257K	﹤0.01%	1983
2021 Q4	$374K	Sell	78,055 -7,000	-8%	-$34.9K	﹤0.01%	1473
2021 Q3	$454K	Sell	85,055 -5,000	-6%	-$25.2K	0.01%	1278
2021 Q2	$461K	Buy	+90,055	New	+$512K	0.01%	1221

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Advisor Networks's AMRX Position: Q2 2022 in Review

Cetera Advisor Networks sold out of Amneal Pharmaceuticals (AMRX) in Q2 2022, closing a stake of 20,055 shares — an estimated $84K sold.

Cetera Advisor Networks first reported a position in AMRX in Q2 2021 and held it in 4 quarters. The position peaked at $461K in Q2 2021. 153 funds tracked by Wall St. Rank hold AMRX as of Q2 2022.

Cetera Advisor Networks reported no remaining Amneal Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Cetera Advisor Networks sold 20,055 Amneal Pharmaceuticals shares in Q2 2022, an estimated $84K.
Cetera Advisor Networks first reported a position in Amneal Pharmaceuticals in Q2 2021 and held it in 4 quarters.
Cetera Advisor Networks's Amneal Pharmaceuticals position peaked at $461K in Q2 2021.
153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2022.

Based on Cetera Advisor Networks's 13F filing for Q2 2022, filed 11 Aug 2022.